Sign in or create an account to add this stock to your watchlist.
About Rite Aid (NYSE:RAD)
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. This segment also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; offers integrated mail-order and specialty and compounding pharmacy services; and provides infertility treatment, as well as drug benefits under the federal government's Medicare Part D program. As of June 20, 2017, the company operated approximately 4,500 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:RAD
CUSIP76775410
Phone717-761-2633
Debt
Debt-to-Equity Ratio2.11
Current Ratio1.37
Quick Ratio0.85
Price-To-Earnings
Trailing P/E Ratio-85.00
Forward P/E Ratio42.50
P/E GrowthN/A
Sales & Book Value
Annual Sales$21.53 billion
Price / Sales0.08
Cash Flow$0.5903 per share
Price / Cash2.88
Book Value$1.50 per share
Price / Book1.13
Profitability
EPS (Most Recent Fiscal Year)($0.02)
Net Income$943.47 million
Net Margins3.60%
Return on Equity-8.25%
Return on Assets-0.71%
Miscellaneous
Employees59,000
Outstanding Shares1,067,390,000
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
How were Rite Aid's earnings last quarter?
Rite Aid (NYSE:RAD) posted its quarterly earnings results on Thursday, April, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.02) by $0.01. The firm earned $5.39 billion during the quarter, compared to the consensus estimate of $5.75 billion. Rite Aid had a negative return on equity of 8.25% and a net margin of 3.60%. The business's revenue for the quarter was down 8.6% on a year-over-year basis. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid issued an update on its FY19 earnings guidance on Thursday, April, 12th. The company provided earnings per share (EPS) guidance of $0.02-0.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.03. The company issued revenue guidance of $21.7-22.1 billion, compared to the consensus revenue estimate of $21.73 billion.
What price target have analysts set for RAD?
8 analysts have issued 1-year price objectives for Rite Aid's shares. Their forecasts range from $1.50 to $4.70. On average, they expect Rite Aid's stock price to reach $2.3063 in the next twelve months. View Analyst Ratings for Rite Aid.
Are investors shorting Rite Aid?
Rite Aid saw a increase in short interest in April. As of April 30th, there was short interest totalling 143,473,913 shares, an increase of 2.6% from the April 13th total of 147,325,348 shares. Based on an average daily trading volume, of 10,937,103 shares, the short-interest ratio is currently 13.1 days. Currently, 13.6% of the shares of the stock are short sold.
Who are some of Rite Aid's key competitors?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, Chairman & CEO (Age 55)
- Mr. Darren W. Karst, Sr. Exec. VP, CFO & Chief Admin. Officer (Age 58)
- Mr. Bryan Everett, Chief Operating Officer of Rite Aid Stores (Age 45)
- Mr. Kermit R. Crawford, Pres & COO (Age 59)
- Mr. Douglas Elwood Donley, Sr. VP & Chief Accounting Officer (Age 56)
Has Rite Aid been receiving favorable news coverage?
News articles about RAD stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Rite Aid earned a coverage optimism score of 0.14 on Accern's scale. They also assigned news coverage about the company an impact score of 47.13 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are Rite Aid's major shareholders?
Rite Aid's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Franklin Resources Inc. (4.81%), OppenheimerFunds Inc. (4.70%), BlackRock Inc. (4.10%), Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp (1.76%), Alpine Associates Management Inc. (0.94%) and Dimensional Fund Advisors LP (0.63%). Company insiders that own Rite Aid stock include Douglas E Donley and Myrtle S Potter. View Institutional Ownership Trends for Rite Aid.
Which institutional investors are selling Rite Aid stock?
RAD stock was sold by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., UBS Group AG, Gabelli Funds LLC, California Public Employees Retirement System, SG Americas Securities LLC, Symons Capital Management Inc., New York State Common Retirement Fund and Teacher Retirement System of Texas. View Insider Buying and Selling for Rite Aid.
Which institutional investors are buying Rite Aid stock?
RAD stock was purchased by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Franklin Resources Inc., Millennium Management LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Dimensional Fund Advisors LP, Interval Partners LP, Nuveen Asset Management LLC and BlackRock Inc.. View Insider Buying and Selling for Rite Aid.
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $1.70.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $1.80 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
Rite Aid (NYSE:RAD) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Rite Aid in the last 12 months. Their average twelve-month price target is $2.3063, suggesting that the stock has a possible upside of 35.66%. The high price target for RAD is $4.70 and the low price target for RAD is $1.50. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 1.88 | 1.88 | 2.00 | 2.00 |
| Ratings Breakdown: | 2 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $2.3063 | $2.3063 | $2.7722 | $3.3556 |
| Price Target Upside: | 35.66% upside | 34.87% upside | 33.28% upside | 88.51% upside |
Rite Aid (NYSE:RAD) Consensus Price Target History
Rite Aid (NYSE:RAD) Analyst Ratings History
Show:
(Data available from 5/22/2016 forward)
Rite Aid (NYSE:RAD) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Rite Aid (NYSE RAD) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.29%
Institutional Ownership Percentage: 50.37%
Rite Aid (NYSE RAD) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/3/2017 | Myrtle S Potter | Director | Sell | 28,189 | $2.09 | $58,915.01 | |  |
| 6/15/2016 | Douglas E Donley | SVP | Sell | 34,106 | $7.77 | $265,003.62 | 82,885 | |
| 7/9/2015 | Tony Montini | EVP | Sell | 353,194 | $8.38 | $2,959,765.72 | | |
| 4/15/2015 | Joseph B Anderson Jr | Director | Sell | 150,000 | $8.25 | $1,237,500.00 | | |
| 4/13/2015 | Robert K Thompson | EVP | Sell | 95,850 | $8.33 | $798,430.50 | | |
| 4/10/2015 | Douglas E Donley | CAO | Sell | 59,404 | $8.21 | $487,706.84 | | |
| 4/10/2015 | Marcy Syms | Director | Sell | 150,000 | $8.26 | $1,239,000.00 | | |
| 12/29/2014 | Tony Montini | EVP | Sell | 49,525 | $7.47 | $369,951.75 | | |
| 12/23/2014 | Tony Montini | EVP | Sell | 259,750 | $6.92 | $1,797,470.00 | | |
| 12/22/2014 | John T Standley | CEO | Sell | 1,700,000 | $6.82 | $11,594,000.00 | | |
| 12/22/2014 | Kenneth Martindale | COO | Sell | 1,043,400 | $6.80 | $7,095,120.00 | | |
| 12/22/2014 | Robert Ivan Thompson | EVP | Sell | 149,231 | $6.80 | $1,014,770.80 | | |
| 7/3/2014 | Robert Ivan Thompson | EVP | Sell | 249,583 | $7.48 | $1,866,880.84 | | |
| 6/24/2014 | Joseph B Anderson Jr | Director | Sell | 26,667 | $7.05 | $188,002.35 | | |
| 6/23/2014 | Robert Ivan Thompson | EVP | Sell | 510,000 | $7.06 | $3,600,600.00 | | |
| 4/22/2014 | Marc Strassler | EVP | Sell | 224,800 | $7.12 | $1,600,576.00 | 699,369 | |
| 4/21/2014 | Frank Vitrano | EVP | Sell | 1,913,925 | $7.08 | $13,550,589.00 | 1,183,384 | |
| 4/16/2014 | Robert Ivan Thompson | EVP | Sell | 25,566 | $7.03 | $179,728.98 | 749,882 | |
| 2/19/2014 | John Standley | CEO | Sell | 1,200,000 | $6.23 | $7,476,000.00 | 2,974,958 | |
| 2/19/2014 | Kenneth Martindale | COO | Sell | 666,667 | $6.23 | $4,153,335.41 | 1,193,252 | |
| 1/21/2014 | Douglas Donley | SVP | Sell | 24,173 | $5.79 | $139,961.67 | 81,628 | |
| 1/3/2014 | John Standley | CEO | Sell | 600,000 | $5.48 | $3,288,000.00 | 2,974,958 | |
| 1/3/2014 | Kenneth Martindale | COO | Sell | 333,333 | $5.48 | $1,826,664.84 | 1,193,252 | |
| 10/18/2013 | Robert K Thompson | EVP | Sell | 250,000 | $5.27 | $1,317,500.00 | | |
| 10/17/2013 | Douglas E Donley | SVP | Sell | 88,700 | $5.27 | $467,449.00 | | |
| 10/17/2013 | Marc A Strassler | EVP | Sell | 100,000 | $5.31 | $531,000.00 | | |
| 10/14/2013 | Frank Vitrano | CFO | Sell | 1,982,900 | $5.00 | $9,914,500.00 | 1,183,384 | |
| 10/4/2013 | Tony Montini | EVP | Sell | 414,500 | $5.21 | $2,159,545.00 | 643,713 | |
| 9/25/2013 | Robert Ivan Thompson | EVP | Sell | 400,000 | $4.81 | $1,924,000.00 | 749,882 | |
| 7/18/2013 | Robert K Thompson | EVP | Sell | 401,655 | $3.01 | $1,208,981.55 | | |
| 7/16/2013 | David Jessick | Insider | Sell | 100,000 | $2.93 | $293,000.00 | | |
| 7/16/2013 | Marc A Strassler | EVP | Sell | 375,000 | $2.96 | $1,110,000.00 | | |
| 7/12/2013 | Douglas E Donley | SVP | Sell | 6,899 | $2.80 | $19,317.20 | | |
| 7/11/2013 | Douglas E Donley | SVP | Sell | 75,378 | $2.78 | $209,550.84 | | |
| 7/11/2013 | Robert Ivan Thompson | EVP | Sell | 375,000 | $2.75 | $1,031,250.00 | | |
| 6/26/2013 | Jean Coutu Group (Pjc) Inc. | Major Shareholder | Sell | 40,500,000 | $2.75 | $111,375,000.00 | | |
(Data available from 1/1/2013 forward)
Rite Aid (NYSE RAD) News Headlines
| Source: |
|
Rite Aid (NYSE:RAD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Rite Aid (NYSE:RAD) Income Statement, Balance Sheet and Cash Flow Statement
Rite Aid (NYSE RAD) Stock Chart for Tuesday, May, 22, 2018
Loading chart…
